Hypothesis: the "metabolic memory", the new challenge of diabetes (Q43180132)

15 November 2017

Hypothesis: the "metabolic memory", the new challenge of diabetes (English)

1 reference

15 November 2017

1

1 reference

15 November 2017

1 December 2009

1 reference

Diabetes Research and Clinical Practice

15 November 2017

1 reference

15 November 2017

86 Suppl 1

1 reference

15 November 2017

S2-6

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

15 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Effect of methylglyoxal on human leukaemia 60 cell growth: Modification of DNA, G1 growth arrest and induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Alpha-oxoaldehyde metabolism and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Enzymatic deglycation of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Mitochondrial ROS-induced ROS release: an update and review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

The role of AMP-activated protein kinase in mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

The human mitochondrial proteome: oxidative stress, protein modifications and oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Postprandial glucose regulation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Importance of measuring products of non-enzymatic glycation of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

Targeting antioxidants to mitochondria: a new therapeutic direction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2809%2970002-6

7 January 2021

10.1016/S0168-8227(09)70002-6

Identifiers

DOI

1 reference

15 November 2017

1 reference

PubMed ID

20115927